Tonix Pharmaceuticals Holding (TNXP) EBITDA Margin (2023 - 2026)
Tonix Pharmaceuticals Holding (TNXP) posted EBITDA Margin of -309.48% for Q2 2026, up 1082.56 percentage points from -1392.04% a year earlier and up 286.36 percentage points from the prior quarter.
Tonix Pharmaceuticals Holding (TNXP) EBITDA Margin (2023 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBITDA Margin at Tonix Pharmaceuticals Holding was -561.14%, up 256.70 percentage points year-over-year; for FY2025, it came in at -944.37%, up 376.02 percentage points from FY2024.
- In prior years, Tonix Pharmaceuticals Holding's EBITDA Margin was -1320.39% in FY2024 (+148.32 pp) and -1468.70% in FY2023.
- The Q2 2026 figure stands as the highest quarterly EBITDA Margin in data going back to Q3 2023.
- On a year-over-year basis, EBITDA Margin increased in five of the last eight quarters, with an average year-over-year change of +355.04 percentage points.
- The strongest year-over-year quarter for EBITDA Margin in the past five years was Q2 2025, with a gain of 2055.01 percentage points; the weakest was Q3 2025, with a drop of 457.97 percentage points.
- According to Business Quant data, EBITDA Margin for the three prior quarters was -595.84% (Q1 2026), -886.79% (Q4 2025) and -991.06% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 39.10% |
| 10 | Tonix Pharmaceuticals Holding | 163.56 Mn | 163.56 Mn | 12.84 Mn | -309.48% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -309.48% |
| Mar 31, 2026 | -595.84% |
| Dec 31, 2025 | -886.79% |
| Sep 30, 2025 | -991.06% |
| Jun 30, 2025 | -1,392.04% |
| Mar 31, 2025 | -640.63% |
| Dec 31, 2024 | -851.43% |
| Sep 30, 2024 | -533.10% |
| Jun 30, 2024 | -3,447.06% |
| Mar 31, 2024 | -811.48% |
| Dec 31, 2023 | -689.81% |
| Sep 30, 2023 | -675.13% |
Tonix Pharmaceuticals Holding EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=TNXP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "TNXP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=TNXP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();